Literature DB >> 33723343

Computational modeling reveals a key role for polarized myeloid cells in controlling osteoclast activity during bone injury repair.

Chen Hao Lo1,2, Etienne Baratchart3, David Basanta4, Conor C Lynch5.   

Abstract

Bone-forming osteoblasts and -resorbing osteoclasts control bone injury repair, and myeloid-derived cells such as monocytes and macrophages are known to influence their behavior. However, precisely how these multiple cell types coordinate and regulate each other over time within the bone marrow to restore bone is difficult to dissect using biological approaches. Conversely, mathematical modeling lends itself well to this challenge. Therefore, we generated an ordinary differential equation (ODE) model powered by experimental data (osteoblast, osteoclast, bone volume, pro- and anti-inflammatory myeloid cells) obtained from intra-tibially injured mice. Initial ODE results using only osteoblast/osteoclast populations demonstrated that bone homeostasis could not be recovered after injury, but this issue was resolved upon integration of pro- and anti-inflammatory myeloid population dynamics. Surprisingly, the ODE revealed temporal disconnects between the peak of total bone mineralization/resorption, and osteoblast/osteoclast numbers. Specifically, the model indicated that osteoclast activity must vary greatly (> 17-fold) to return the bone volume to baseline after injury and suggest that osteoblast/osteoclast number alone is insufficient to predict bone the trajectory of bone repair. Importantly, the values of osteoclast activity fall within those published previously. These data underscore the value of mathematical modeling approaches to understand and reveal new insights into complex biological processes.

Entities:  

Mesh:

Year:  2021        PMID: 33723343      PMCID: PMC7961065          DOI: 10.1038/s41598-021-84888-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  98 in total

1.  Interleukin (IL)-13 and IL-4 inhibit proliferation and stimulate IL-6 formation in human osteoblasts: evidence for involvement of receptor subunits IL-13R, IL-13Ralpha, and IL-4Ralpha.

Authors:  A Frost; K B Jonsson; H Brändström; S Ljunghall; O Nilsson; O Ljunggren
Journal:  Bone       Date:  2001-03       Impact factor: 4.398

2.  Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

Authors:  T Kon; T J Cho; T Aizawa; M Yamazaki; N Nooh; D Graves; L C Gerstenfeld; T A Einhorn
Journal:  J Bone Miner Res       Date:  2001-06       Impact factor: 6.741

3.  Bone Mass Is Compromised by the Chemotherapeutic Trabectedin in Association With Effects on Osteoblasts and Macrophage Efferocytosis.

Authors:  Benjamin P Sinder; Laura Zweifler; Amy J Koh; Megan N Michalski; Lorenz C Hofbauer; Jose Ignacio Aguirre; Hernan Roca; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2017-08-31       Impact factor: 6.741

4.  The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation.

Authors:  V Everts; J M Delaissé; W Korper; D C Jansen; W Tigchelaar-Gutter; P Saftig; W Beertsen
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

5.  Model-based decision rules reduce the risk of molecular relapse after cessation of tyrosine kinase inhibitor therapy in chronic myeloid leukemia.

Authors:  Matthias Horn; Ingmar Glauche; Martin C Müller; Rüdiger Hehlmann; Andreas Hochhaus; Markus Loeffler; Ingo Roeder
Journal:  Blood       Date:  2012-11-21       Impact factor: 22.113

6.  Macrophage activation unveiled.

Authors: 
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

7.  A special healing pattern in stable metaphyseal fractures.

Authors:  Wen Tao Chen; Da Cheng Han; Pei Xun Zhang; Na Han; Yu Hui Kou; Xiao Feng Yin; Bao Guo Jiang
Journal:  Acta Orthop       Date:  2015-01-13       Impact factor: 3.717

8.  TNF-α has both stimulatory and inhibitory effects on mouse monocyte-derived osteoclastogenesis.

Authors:  Yixuan Cao; Ineke D C Jansen; Sara Sprangers; Teun J de Vries; Vincent Everts
Journal:  J Cell Physiol       Date:  2017-07-17       Impact factor: 6.384

9.  Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune response.

Authors:  James K Chan; Graeme E Glass; Adel Ersek; Andrew Freidin; Garry A Williams; Kate Gowers; Ana I Espirito Santo; Rosemary Jeffery; William R Otto; Richard Poulsom; Marc Feldmann; Sara M Rankin; Nicole J Horwood; Jagdeep Nanchahal
Journal:  EMBO Mol Med       Date:  2015-05       Impact factor: 14.260

10.  The monocyte to macrophage transition in the murine sterile wound.

Authors:  Meredith J Crane; Jean M Daley; Olivier van Houtte; Samielle K Brancato; William L Henry; Jorge E Albina
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more
  2 in total

1.  Integrated computational and in vivo models reveal Key Insights into macrophage behavior during bone healing.

Authors:  Etienne Baratchart; Chen Hao Lo; Conor C Lynch; David Basanta
Journal:  PLoS Comput Biol       Date:  2022-05-13       Impact factor: 4.779

Review 2.  New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach.

Authors:  Magdalena Woźniczka; Katarzyna Błaszczak-Świątkiewicz
Journal:  Molecules       Date:  2021-10-27       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.